- SG$27.20m
- SG$23.32m
- SG$12.81m
- 98
- 77
- 65
- 94
Annual income statement for Medinex, fiscal year end - March 31st, SGD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 10.8 | 12 | 13 | 12.6 | 12.8 |
| Cost of Revenue | |||||
| Gross Profit | 7.66 | 8.57 | 9.48 | 9.68 | 9.93 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 8.15 | 9.5 | 10.9 | 11.7 | 9.85 |
| Operating Profit | 2.63 | 2.5 | 2.03 | 0.897 | 2.96 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 3.86 | 3.27 | 2.04 | 1.02 | 2.98 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 3.55 | 2.9 | 1.69 | 0.867 | 2.83 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 3.49 | 2.81 | 1.7 | 1.03 | 2.83 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 3.49 | 2.81 | 1.7 | 1.03 | 2.83 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.022 | 0.024 | 0.013 | 0.012 | 0.021 |
| Dividends per Share |